IP Verse

Pharmaceutical Composition Comprising Glycopyrrolate - EP3915555

The patent EP3915555 was granted to Mexichem Fluor DE CV on Jun 28, 2023. The application was originally filed on Sep 18, 2017 under application number EP21183659A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3915555

MEXICHEM FLUOR DE CV
Application Number
EP21183659A
Filing Date
Sep 18, 2017
Status
Granted And Under Opposition
May 26, 2023
Grant Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELKINGTON AND FIFEMar 28, 2024ELKINGTON AND FIFEADMISSIBLE
HGFMar 28, 2024HGFADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONUS6585958
OPPOSITIONWO2005105043
OPPOSITIONWO2010138862
OPPOSITIONWO2011076843
OPPOSITIONWO2012110770
OPPOSITIONWO2012156711
OPPOSITIONWO2013054135
OPPOSITIONWO2013054137
OPPOSITIONWO2014170689
OPPOSITIONWO2014190204
OPPOSITIONWO2015101575
OPPOSITIONWO2015101576
SEARCHWO2012110770
SEARCHWO2012156711

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION BEVESPI AEROSPHERE™ (glycopyrrolate and formoterol fumarate) inhalation aerosol, for oral inhalation use", HIGHLIGHTS OF PRESCRIBING INFORMATION, FDA Food and Drug Administration, (20160101), pages 1 - 37, HIGHLIGHTS OF PRESCRIBING INFORMATION , URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208294s000lbl.pdf, XP093180446-
OPPOSITION- Anonymous, "ICSC 1281 - 1,1,1,2-TETRAFLUOROETHANE", International Chemical Safety Card, IPCS Inchem, (19980301), pages 1 - 2, International Chemical Safety Card, URL: https://www.inchem.org/documents/icsc/icsc/eics1281.htm, XP093180427-
OPPOSITION- Anonymous, "ICSC 1729 - 1,1-DIFLUOROETHANE", International Chemical Safety Card, IPCS Inchem, (20090301), pages 1 - 2, International Chemical Safety Card, URL: https://www.inchem.org/documents/icsc/icsc/eics1729.htm, XP093180426-
OPPOSITION- Noakes Tim, Corr Stuart, "The Future of Propellants for pMDIs", DDL27, Drug Delivery to the Lungs 27, The Aerosol Soceity, (20161207), pages 1 - 4, XP093180449-
OPPOSITION- Vasiliou Christina, "Bevespi Aerosphere Product Analysis", Datamonitor Healthcare, Datamonitor Healthcare, (20160408), pages 1 - 14, Datamonitor Healthcare, URL: http://www.datamonitorhealthcare.com, XP093180441-
OPPOSITION- Verbeeck, R.K. ; Kanfer, I. ; Walker, R.B., "Generic substitution: The use of medicinal products containing different salts and implications for safety and efficacy", European Journal of Pharmaceutical Sciences, Elsevier Amsterdam, NL, NL , (20060501), vol. 28, no. 1-2, doi:10.1016/j.ejps.2005.12.001, ISSN 0928-0987, pages 1 - 6, XP025137295
OPPOSITION- Lena Ernstgrd; Bengt Sjgren; Wolfgang Dekant; Tobias Schmidt; Gunnar Johanson;, "Uptake and disposition of 1,1-difluoroethane (HFC-152a) in humans", Toxicology Letters, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20111125), vol. 209, no. 1, doi:10.1016/j.toxlet.2011.11.028, ISSN 0378-4274, pages 21 - 29, XP028436962
OPPOSITION- Graepel P., Alexander D.J., "CFC Replacements: Safety Testing, Approval for Use in Metered Dose Inhalers", Journal of Aerosol Medicine, (19910901), vol. 4, no. 3, doi:10.1089/jam.1991.4.193, ISSN 0894-2684, pages 193 - 200, XP093180431
OPPOSITION- Simmonds P. G., Rigby M., Manning A. J., Lunt M. F., O'doherty S., Mcculloch A., Fraser P. J., Henne S., Vollmer M. K., Mühle J., Weiss R. F., Salameh P. K., Young D., Reimann S., Wenger A., Arnold T., Harth C. M., Krummel P. B., Steele L. P., Dunse B. L., Miller B. R., Lunder C. R., Hermansen O., Schmidbauer N., Saito T., Yokouchi Y., Park S., Li S., Yao B., Zhou L. X., Arduini J., Maione M., Wang R. H. J., Ivy D., Prinn R. G., "Global and regional emissions estimates of 1,1-difluoroethane (HFC-152a, CH<sub>3</sub>CHF<sub>2</sub>) from in situ and air archive observations", Atmospheric Chemistry and Physics, (20160118), vol. 16, no. 1, doi:10.5194/acp-16-365-2016, ISSN 1680-7324, pages 365 - 382, XP093180414

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents